INTRODUCTION
Proteoglycans (PGs) are cell surface molecules and essential components of extracellular matrices regulating cell-cell and cell-matrix interactions, cell proliferation, differentiation and development. PGs are composed of a protein core with variable glycosaminoglycan (GAG) side chains, which are attached to serine residues via a tetrasaccharide linker (Fig. 1) . Recently, a group of related disorders due to defects in one of the four steps in synthesis of the common linker region has been described [Nakajima et al., 2013] . These multisystem disorders are referred to as "linkeropathies" [Freeze 2006; Nakajima et al., 2013] .
The enzymes involved in the synthesis of the common linker region and their corresponding genes are xylosyltransferases 1 and 2 (XYLT1 and XYLT2), galactosyltransferase 1 (B4GALT7) and galactosyltransferase 2 (B3GALT6) and glucuronosyltransferase 1 (B3GAT3) [Haltiwanger and Lowe 2003; Sugahara et al., 2003; H€ acker et al., 2005; Bishop et al., 2007] , and bi-allelic mutations in most genes have been reported to cause human disease. Mutations in XYLT1 cause Desbuquois dysplasia type 2 (OMIM #615777), previously reported in nine patients [Bui et al., 2014; Schreml et al., 2014] . Mutations in B4GALT7 are associated with the progeroid type of Ehlers-Danlos syndrome (OMIM #130070), previously reported in 26 patients [Kresse et al., 1987; Faiyaz-Ul-Haque et al., 2004; Guo et al., 2013; Cartault et al., 2015] . Mutations in B3GALT6 are associated with spondyloepimetaphyseal dysplasia with joint laxity, type 1 (OMIM # 271640) reported in 16 patients [Malfait et al., 2013; Nakajima et al., 2013] . A single homozygous mutation in B3GAT3, involved in the final step of linker region synthesis, has been reported in six patients with multiple joint dislocations, short stature, craniofacial dysmorphism and congenital heart defects (OMIM #245600) in two families [Baasanjav et al., 2011; von Oettingen et al., 2014] .
Here, we describe a patient from a consanguineous family with a novel homozygous B3GAT3 mutation and a very severe phenotype, expanding the phenotype associated with this disorder. We review the phenotypic features of the linkeropathies associated with mutations in XYLT1, B4GALT7, B3GALT6, and B3GAT3.
CLINICAL REPORT
The patient was a 12-month-old Mexican boy born to parents who were second cousins once removed, whose family history was negative for congenital or skeletal anomalies. Routine ultrasound at 19 weeks estimated gestation identified bilateral clubfeet, clenched hands, and increased nuchal translucency. A structural heart defect was noted and initially thought to be a hypoplastic left heart. Cell-free DNA aneuploidy screen was negative.
The infant was delivered vaginally at term and had a birth weight of 2.56 kg (4th centile), length of 44.5 cm (À2.93 SD) and head circumference of 33 cm (11th centile). At birth, the previously identified clubfeet and clenched hands were present along with a large anterior fontanelle, hypertelorism, bilateral glaucoma, short and upturned nose with a flat nasal bridge, anteverted nares, and a short neck with redundant tissue (Fig.2 A-C) . His upper extremities had decreased flexion creases on interphalangeal joints, camptodactyly, arachnodactyly, ulnar deviation of fingers with the left 2nd and 3rd fingers overlapping the 4th and 5th ( Fig. 2D and E) . His lower extremities showed bilateral sandal gaps (Fig. 2F) . He also had significant hypotonia and lymphedema.
A skeletal survey revealed diffuse demineralization with bowed humeri, bilateral radio-ulnar synostosis, metaphyseal widening, femur fractures, and clubfeet; no joint dislocations were noted. The survey showed a large anterior fontanelle, 11 pairs of ribs and a small thorax (Fig. 3A, 3C and 3D ). The small thorax resulted in restrictive lung disease that required significant respiratory support with upper respiratory infections. At 3 months, our patient began to require supplemental oxygen that ultimately resulted in a 2 months long intubation. He was slowly weaned to minimal respiratory support at night when he developed rhinovirus at age 10 months. This resulted in another intubation and slow respiratory wean. During the first year, the patient has had approximately 25 fractures in all four extremities and vertebrae (Fig. 3E) ; some fractures were incurred during routine blood pressure monitoring. Pamidronate administration began around six months of age. After two months, zones of calcification with sclerotic metaphyseal bands were evident, consistent with bisphosphonate therapy; however, our patient continued to have fractures after six months of therapy. By 12 months of age, plain films of the patient's abdomen and pelvis showed short ilia with flat acetabular angles (Fig. 3B ).
Postnatal echocardiogram revealed that the patient did not have a hypoplastic left heart but rather a large atrial septal defect, ventricular septal defect and a patent ductus arteriosus. At about 3 months of age, brainstem auditory evoked response evaluation showed moderate conductive hearing loss bilaterally. At 6 months of age, trabeculotomy for the patient's bilateral glaucoma was attempted, but discontinued because of uveal prolapse due to marked scleral thinning. A brain MRI at 2 days of age revealed multiple foci of infarction in the left cerebral hemisphere and bilateral supra-and infra-tentorial subdural hematomas overlying the bilateral parietooccipital lobes and bilateral cerebellar hemispheres. A subsequent thrombophilia work up was negative. At 12 months of age, a chest X-ray revealed a Morgagni type diaphragmatic hernia. Development at 9 months showed that our patient was beginning to bat objects and have some brief consonant babbling, but he was unable to roll over or sit independently.
GENETIC TESTING
The genetic evaluation began with analysis of very long chain fatty acids given the large fontanelle, hypotonia and flat nasal bridge; however, this test was negative. Other biochemical testing included a sterol panel and transferrin and apolipoprotein CIII isoform analysis for disorders of glycosylation and these tests were also negative. SNP microarray revealed a 121-201 kb deletion of PARK2 that was not thought to contribute to the patient's phenotype. In addition, multiple long stretches of homozygosity of at least 3 Mb were noted, which comprised approximately 265 Mb or 13% of the autosomal genome. Because of the significant degree of homozygosity, the possibility of at least one autosomal recessive condition was considered. All OMIM genes with an autosomal recessive phenotype were identified using the Santa Cruz Genome Browser (http://www.genome.ucsc.edu). Consequently, a number of interesting candidate genes were considered, initially focusing on the genes with associated with multiple fractures and radio-ulnar synostosis. WNT1 (multiple fractures and hypotonia), B4GALT7 (glaucoma and radio-ulnar synostosis in progeroid Ehlers-Danlos syndrome), B3GALT6 (multiple fractures and spatulate terminal phalanges), and IFITM5 (multiple fractures with marked density at the epiphyseal-metaphyseal boundaries) sequences were all normal. Sequence analysis of B3GAT3 revealed a novel homozygous missense mutation p.Gly223Ser, which was located within a 10.55 Mb region of homozygosity. Because our patient's phenotype was more severe than reported in the literature, there was concern that the B3GAT3 mutation may not explain all his features and that the patient may have an additional autosomal recessive syndrome. Consequently, clinical exome sequence analysis identified the same B3GAT3 mutation but did not reveal additional causative mutations. Functional studies could not be performed because the family declined further genetic analyses.
DISCUSSION
B3GAT3 encodes the 335 amino acid glucuronosyltransferase I protein that catalyzes the addition of glucuronic acid, the final sugar moiety in the tetrasaccharide linker region [Kitagawa et al., 1998 ]. A p.Arg277Gln mutation has been reported in two consanguineous families, both from the United Arab Emirates. The first report described five affected siblings [Baasanjav et al., 2011 ] while the second report described a single affected child [von Oettingen et al., 2014] . Baasanjav et al. [2011] performed functional studies on two siblings with the homozygous p.Arg277Gln mutations and showed that the glucuronosyltransferase I activity was decreased to 3-5% of age-matched control levels. As hypothesized, they showed that the mutation resulted in a partial deficiency of all three Oglycanated proteoglycans (dermatan sulfate, chondroitin sulfate and heparan sulfate) [Baasanjav et al., 2011] .
The homozygous p.Gly223Ser mutation has not previously been reported in humans. Review of the ExAC browser (http://exac. broadinstitute.org) revealed that this mutation was present in 1 of 119,290 alleles with a frequency of 8.383e
À6
. In contrast, the p. Arg277Gln mutation was present in 3 of 120,974 alleles with a frequency of 2.48e
À5
. There were no homozygotes for either mutation. PolyPhen2 [Adzhubei et al., 2010] analysis of the p. Gly223Ser was predicted to be "probably damaging" with a score of 0.935 while the p.Arg277Gln mutation was predicted to be "possibly damaging" with a score of 0.763. The GERP score for the p. Gly223Ser mutation was 3.78 while the p.Arg277Gln mutation was 5.31. Additionally, Gulberti et al. [2005] found that substituting an alanine residue for either Gly222 or Gly223 markedly impaired the glucuronosyltransferase 1 activity of recombinant human glucuronosyltransferase 1 in yeast cells as part of a study investigating the specificity of glycosyltransferases.These analyses bolster the conclusion that both the p.Gly223Ser and the p.Arg277Gln mutations are likely pathogenic.
Our patient has many features present in the six previously reported patients with B3GAT3 mutations (Table I) , including short stature, prominent forehead and eyes, broad fingers and toes, and cardiovascular abnormalities [Baasanjav et al., 2011; von Oettingen et al., 2014] . He has the additional features of blue sclerae, glaucoma, arachnodactyly, hearing loss, multiple fractures, a diaphragmatic hernia and a small thorax. None of these features have been previously reported in an individual with a B3GAT3 mutation. Even at 12 months of age, it is clear that our patient has a more severe phenotype than reported previously and it is expected that he will have a significantly different clinical course, expanding the phenotypic spectrum associated with B3GAT3 mutations.
While our patient has features not previously reported in patients with B3GAT3 mutations, some of these have been reported in other linkeropathies (Table I) . For example, multiple fractures and blue sclerae have been reported in patients with B3GALT6 mutations [Malfait et al., 2013] . Blue sclerae and small chests have also been reported in patients with XYLT1 mutations [Bui et al., 2014] . While hypotonia has not been reported in individuals with B3GAT3 mutations, it has been reported in all other linkeropathies. These similarities suggest a phenotypic overlap in individuals who have a deficiency in the biosynthesis of the common linker region [Kresse et al., 1987; Faiyaz-Ul-Haque et al., 2004; Guo et al., 2013; Malfait et al., 2013; Nakajima et al., 2013; Bui et al., 2014 ].
This conclusion is further supported by the phenotypic features shared among all of the linkeropathies (Fig. 4) . These include short stature, prominent forehead and eyes, pectus abnormalities, joint laxity and dislocations, broad fingertips, foot abnormalities, hypotonia, and developmental delays [Kresse et al., 1987; Faiyaz-UlHaque et al., 2004; Baasanjav et al., 2011; Guo et al., 2013; Malfait et al., 2013; Nakajima et al., 2013; Bui et al., 2014; Schreml et al., 2014; von Oettingen et al., 2014; Cartault et al., 2015] . Other features are present in some disorders, such as cardiac defects, radio-ulnar synostosis, monkey wrench or Swedish key appearance of the femora, and atrophic scars. This phenotypic disparity may be due to varying levels of gene expression in different tissues as suggested by Nakajima et al. [2013] . Another consideration may be that the linkeropathies have not been fully characterized. Several previous reports focused on a particular aspect of the phenotype, such as the skeletal features, and may not have described other systemic features that were present.
In summary, we describe a severe phenotype caused by a homozygous c.667G>A mutation in B3GAT3, resulting in the p.Gly223Ser change in glucuronosyltransferase I. This expands the number of syndromes caused by homozygous B3GAT3 mutations. Based on our experience, we suggest considering B3GAT3 mutations in a patient with multiple fractures, prominent forehead and eyes, hypotonia and developmental delay, who had a negative evaluation for osteogenesis imperfecta. Furthermore, a clinician should consider the linkeropathies when a patient presents with short stature, prominent forehead and eyes, joint laxity and dislocations, iliac and metaphyseal abnormalities, broad fingertips, foot abnormalities and developmental delay. As additional clinical descriptions of these disorders are reported, further insight will characterize the linkeropathies individually and as a group.
